OR | 95% CI | p Values | ||
---|---|---|---|---|
Lower limit | Upper limit | |||
Weekdays | 1 | |||
Weekends | 1.42 | 1.40 | 1.43 | <0.0001 |
Year | ||||
1999 | 1.00 | |||
2000 | 0.94 | 0.93 | 0.96 | <0.0001 |
2001 | 0.95 | 0.93 | 0.97 | |
2002 | 1.00 | 0.98 | 1.02 | |
2003 | 1.03 | 1.02 | 1.05 | |
2004 | 1.02 | 1.00 | 1.04 | |
2005 | 1.05 | 1.03 | 1.07 | |
2006 | 0.97 | 0.96 | 0.99 | |
2007 | 0.91 | 0.90 | 0.93 | |
2008 | 0.89 | 0.87 | 0.91 | |
2009 | 0.81 | 0.80 | 0.83 | |
Age group (years) | ||||
<5 | 0.06 | 0.06 | 0.07 | |
5–9 | 0.05 | 0.04 | 0.06 | <0.0001 |
10–14 | 0.05 | 0.05 | 0.07 | |
15–19 | 0.11 | 0.10 | 0.12 | |
20–24 | 0.12 | 0.11 | 0.13 | |
25–29 | 0.15 | 0.14 | 0.16 | |
30–34 | 0.24 | 0.22 | 0.25 | |
35–39 | 0.39 | 0.37 | 0.41 | |
40–44 | 0.62 | 0.59 | 0.65 | |
45–49* | 1 | |||
50–54 | 1.56 | 1.50 | 1.62 | |
55–59 | 2.28 | 2.20 | 2.36 | |
60–64 | 3.31 | 3.20 | 3.42 | |
65–69 | 4.54 | 4.39 | 4.69 | |
70–74 | 6.08 | 5.89 | 6.28 | |
75–79 | 8.00 | 7.75 | 8.26 | |
80–84 | 10.19 | 9.88 | 10.52 | |
≥85 | 13.77 | 13.35 | 14.20 | |
Gender | ||||
Male | 1 | |||
Female | 0.85 | 0.84 | 0.85 | <0.0001 |
Socioeconomic status (quintile) | ||||
1 | 1 | |||
2 | 1.00 | 0.99 | 1.01 | <0.0001 |
3 | 0.98 | 0.97 | 0.99 | |
4 | 0.97 | 0.96 | 0.99 | |
5 | 0.93 | 0.92 | 0.95 | |
Number of comorbidities | ||||
None | 1 | |||
1 | 1.24 | 1.23 | 1.26 | <0.0001 |
2 | 1.34 | 1.32 | 1.35 | |
3 | 0.90 | 0.89 | 0.91 | |
4 | 0.50 | 0.49 | 0.51 | |
5 or more | 0.11 | 0.10 | 0.11 |
The adjusted OR along with lower and upper limits of the 95% CIs are shown in each row along with the significance for the test and significance for the trend within each category, if appropriate. These were derived from a logistic regression analysis. Note that this analysis includes only those admissions where complete records of all potential confounders were kept.
*Patients under theage group of 45–49 were used as the baseline group for the calculation of OR.